Web Desc
Atherosclerosis: Lessons Learned and Concepts Challenged
Organizer(s): Laura F. Michael, Gerard Pasterkamp and Sekar Kathiresan
Date: February 04 - 08, 2018
Location: Sagebrush Inn & Suites, Taos, NM, USA
Sponsored by Amgen Inc., MedImmune and Novo Nordisk A/S
Summary of Meeting:
Atherosclerosis is a chronic, systemic disease process whereby fatty deposits, inflammation and fibrosis accumulate in arterial vessel walls. Organ systems, including heart, brain and kidneys, as well as extremities, can be damaged, leading to atherosclerosis-driven clinical outcomes. According to the American Heart Association, 15.5 million Americans have coronary heart disease, of which 7.6 million experienced myocardial infarction. These statistics are reflective of global incidence. Treatment of atherosclerosis often begins with robust cholesterol-lowering treatments, yet many patients continue to experience cardiovascular events. Recent attempts to provide cardiovascular protection to such patients have included anti-inflammatory and HDL-raising therapeutic approaches that have yielded little benefit. Building knowledge of atherosclerosis disease etiology, defining unique attributes of patient differences as simple as sex or genetic inheritance, and using technology to identify patients with early disease is foundational for the scientific community to develop urgently needed therapeutics. The current concept of acute coronary syndrome (“the vulnerable plaque”) and widely applied animal models are debated because clinical presentation, underlying pathology and pathogenetic mechanisms are subject to change due to improved medical treatment. The goals of this meeting are to: 1) Challenge current dogma of atherosclerosis etiology and explore intra-organ cross-talk that may underlie disease evolution; 2) Consider emerging risk factors and their origins as intervention targets; and 3) Explore cutting-edge technologies to discover new therapeutic targets and approaches for drug development. By bringing together scientists from preclinical to clinical settings and from industry to academic institutions, this conference will nurture discussions to translate breakthrough discoveries into therapeutics.
Scholarship Deadline: October 5 2017
Discounted Abstract Deadline: October 5 2017
Abstract Deadline: November 7 2017
Discounted Registration Deadline: December 7 2017
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

Amgen Inc.
MedImmuneNovo Nordisk A/S
We gratefully acknowledge additional support for this conference from:
Journal of Lipid Research
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Regeneron Pharmaceuticals, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1 R13 HL140612-01
Funding for this conference was made possible (in part) by 1 R13 HL140612-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, February 04 | 4:00PM - 8:00PM
Arrival and Registration
Room: Sagebrush Lobby & Cantina


Sunday, February 04 | 6:00PM - 8:00PM
Welcome Mixer
Room: Sagebrush Lobby & Cantina
No registration fees are used to fund alcohol served at this function.

Monday, February 05 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 1 of 7
* Daniel J. Rader, University of Pennsylvania, USA

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 2 of 7
Peter Libby, Brigham and Women's Hospital, USA
Requiem for the Vulnerable Plaque, Challenging Current Concepts

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 3 of 7
Sekar Kathiresan, Verve Therapeutics, USA
Inherited Basis for Myocardial Infarction

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1


Coffee Break

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 5 of 7
Gerard Pasterkamp, University Medical Center Utrecht, Netherlands
Geno-Phenotyping of the Vulnerable Plaque and Patient

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 6 of 7
Philippe Boucher, University of Strasbourg, France
Short Talk: Wnt5a Decreases mTORC1/SREBP2 Activity and Promotes Endosomal Cholesterol Trafficking to the ER in Mice and in Human Vascular Smooth Muscle Cells

Monday, February 05 | 8:00AM - 11:00AM
The Natural History of Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 7 of 7
Sumeet A. Khetarpal, University of Pennsylvania, USA
Short Talk: A Human APOC3 Missense Variant and Monoclonal Antibody Accelerate apoC-III Clearance and Lower Triglyceride-rich Lipoprotein Levels

Monday, February 05 | 11:00AM - 5:00PM
On Own for Lunch


Monday, February 05 | 11:00AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Monday, February 05 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 1 of 8
* Ira G. Schulman, University of Virginia Health System, USA

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 2 of 8
Liam Brunham, University of British Columbia, Canada
Genetic Regulation of HDL Cholesterol Levels during Sepsis

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 3 of 8
Ruchi Gupta, MedImmune/AstraZeneca, USA
LOX-1: The Cause of and Solution to Inflammation and Lipid Accumulation in Atherosclerosis

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 4 of 8
Anna Kerstin Emy Hultgardh, Lund University, Sweden
IL-22 Deficiency Reduces Formation of Advanced Atherosclerotic Carotid Plaques in ApoE-Deficient Mice

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 5 of 8
Ashok Kumar Kumawat, Orebro University, Sweden
Targeting IL-6/IL17A in Vascular Inflammation using Affibody Molecules

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 6 of 8
Mulugeta Melkie Zegeye, Orebro University, Sweden
Activation of JAK/STAT3 and PI3K Pathways Are Crucial for MCP-1 Induction by IL6 Trans-Signaling in Human Endothelial Cells

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 7 of 8
Sean Allen, Northwestern University, USA
Targeted Inhibition of NF-?B in Mouse Models of Atherosclerosis Results in Sex-Dependent Immunomodulation

Monday, February 05 | 2:30PM - 4:30PM
Workshop 1
Room: Chamisa Ballroom 1

Speaker 8 of 8
Anna Mathew, University of Michigan, USA
Myeloperoxidase-Derived Oxidants Damage Artery Wall Proteins in an Animal Model of Chronic Kidney Disease-Accelerated Atherosclerosis

Monday, February 05 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Monday, February 05 | 5:00PM - 7:00PM
Lipoprotein Risk Factors
Room: Chamisa Ballroom 1

Speaker 1 of 4
* Laura F. Michael, Eli Lilly and Company, USA

Monday, February 05 | 5:00PM - 7:00PM
Lipoprotein Risk Factors
Room: Chamisa Ballroom 1

Speaker 2 of 4
Kiran Musunuru, University of Pennsylvania, USA
Therapeutic Genome Editing as a Cure for Atherosclerosis

Monday, February 05 | 5:00PM - 7:00PM
Lipoprotein Risk Factors
Room: Chamisa Ballroom 1

Speaker 3 of 4
Anne Tybjærg-Hansen, Copenhagen University Hospital, Denmark
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology

Monday, February 05 | 5:00PM - 7:00PM
Lipoprotein Risk Factors
Room: Chamisa Ballroom 1

Speaker 4 of 4
Daniel J. Rader, University of Pennsylvania, USA
Functionalizing HDL Cholesterol

Monday, February 05 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Monday, February 05 | 7:30PM - 10:00PM
Poster Session 1
Room: Chamisa Ballroom 2


Tuesday, February 06 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 1 of 7
* Siddhartha Jaiswal, Stanford University, USA

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 2 of 7
J. Mark Brown, Cleveland Clinic, USA
Selective Small Molecule Inhibition of Gut Microbial Enzymes for the Treatment of Cardiometabolic Disorders

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 3 of 7
Joerg Heeren, University Medical Center Hamburg-Eppendorf, Germany
Protective Role of Brown Adipose in Atherosclerosis Development

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1


Coffee Break

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 5 of 7
Laura F. Michael, Eli Lilly and Company, USA
Diabetes and Atherosclerosis: Anti-Diabetic Agents that Improve Cardiovascular Outcomes

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 6 of 7
Robert C. Bauer, Columbia University, USA
Short Talk: Adipose Knockout of Tribbles-1, a GWAS Locus for Coronary Artery Disease, Reduces Plasma Lipids and Increases Circulating Adiponectin

Tuesday, February 06 | 8:00AM - 11:00AM
Diabetes, Obesity and Atherosclerosis
Room: Chamisa Ballroom 1

Speaker 7 of 7
Brian Parks, University of Wisconsin-Madison, USA
Journal of Lipid Research Junior Investigator Award: Short Talk: Leveraging Mouse Liver Co-Expression Networks and Human Lipid GWAS Data to Identify and Validate Cholesterol Metabolism Genes

Tuesday, February 06 | 11:00AM - 5:00PM
On Own for Lunch


Tuesday, February 06 | 11:00AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Tuesday, February 06 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Tuesday, February 06 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Tuesday, February 06 | 5:00PM - 7:00PM
The Inflammation Hypothesis
Room: Chamisa Ballroom 1

Speaker 1 of 4
* Katey Rayner, University of Ottawa, Canada

Tuesday, February 06 | 5:00PM - 7:00PM
The Inflammation Hypothesis
Room: Chamisa Ballroom 1

Speaker 2 of 4
Ziad Mallat, University of Cambridge, UK
Immune Modulation in Atherosclerosis

Tuesday, February 06 | 5:00PM - 7:00PM
The Inflammation Hypothesis
Room: Chamisa Ballroom 1

Speaker 3 of 4
Jan Nilsson, Lund University, Sweden
Autoimmunity, Injury and Repair as Potential Targets for Intervention in Atherosclerosis

Tuesday, February 06 | 5:00PM - 7:00PM
The Inflammation Hypothesis
Room: Chamisa Ballroom 1

Speaker 4 of 4
Paul M. Ridker, Brigham and Women's Hospital, Harvard Medical School, USA
Anti-inflammatory Therapies for Chronic Atherosclerosis

Tuesday, February 06 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Tuesday, February 06 | 7:30PM - 10:00PM
Poster Session 2
Room: Chamisa Ballroom 2


Wednesday, February 07 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 1 of 8
* Gerard Pasterkamp, University Medical Center Utrecht, Netherlands

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 2 of 8
Salim Yusuf, McMaster University, Canada
How Can We Reduce Premature CVD Globally in a Generation?

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 3 of 8
Sudha B. Biddinger, Boston Children's Hospital, Harvard Medical School, USA
Beyond Hyperglycemia: Novel Mediators of Diabetes-Associated Cardiovascular Disease

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1


Coffee Break

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 5 of 8
Seppo Yla-Herttuala, University of Eastern Finland, Finland
Epigenetics, VEGFs and Noncoding RNAs in Atherosclerosis and Angiogenesis

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 6 of 8
Robert E. Gerszten, Beth Israel Deaconess Medical Center, USA
Translating Exercise into Reduced Atherosclerosis Burden

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 7 of 8
Brian Bennett, US Department of Agriculture, USA
Short Talk: Genetic and MicroRNA Association with the Cardiometabolic Disease Risk Factor TMAO

Wednesday, February 07 | 8:00AM - 11:15AM
The Milieu Exterieur
Room: Chamisa Ballroom 1

Speaker 8 of 8
Michael C. Petriello, University of Kentucky, USA
Short Talk: Serum Levels of Dioxin-Like Pollutants Are Positively Associated with the Cardiometabolic Disease Risk Biomarker Trimethylamine-N-oxide in Leaner Individuals

Wednesday, February 07 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, February 07 | 11:15AM - 1:00PM
Poster Setup
Room: Chamisa Ballroom 2


Wednesday, February 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Chamisa Ballroom 2


Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 1 of 9
* Dominique P.V. de Kleijn, University Medical Center Utrecht, Netherlands

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 2 of 9
Camilla Gustafsen, Aarhus University, Denmark
Heparan Sulfate Proteoglycans Present PCSK9 to the LDL Receptor

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 3 of 9
Fan E. Mo, National Cheng Kung University, Taiwan
CCN1 and Its Receptor Integrin alpha6beta1 Instigate a Vicious Circle to Accelerate Disturbed Flow-Induced Atherosclerosis

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 4 of 9
Andrew J. Morris, University of Kentucky, USA
Functional Validation of PPAP2B Gene Variants as Determinants of Coronary Artery Disease Risk

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 5 of 9
Edward R. O'Brien, University of Calgary, Canada
Natural Antibodies to HSP27 Are Novel Biomarkers for Cardiovascular Health:
HSP27 Immunization Attenuates PCSK9 Transcription and Atherogenesis


Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 6 of 9
Ira G. Schulman, University of Virginia Health System, USA
Regulation of HDL Function and Inflammation by Liver X Receptors

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 7 of 9
Tapan Shah, Rutgers New Jersey Medical School, USA
Sex Specific Differences in Post-Transcriptional Gene Regulation of BMP2 in Cardiovascular Calcification

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 8 of 9
Vincent J. Venditto, University of Kentucky, USA
Anti-ApoA-I Antibody Profiles Predict Cardiovascular Disease Outcomes in Patients and in a Mouse Model of Atherosclerosis

Wednesday, February 07 | 2:30PM - 4:30PM
Workshop 2
Room: Chamisa Ballroom 1

Speaker 9 of 9
Hong Yang, Meharry Medical College, USA
Upregulation of ABCA1 Transcription and Inhibition of ABCA1 Protein Degradation by VLDLR/apoER2 Pathway

Wednesday, February 07 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Wednesday, February 07 | 5:00PM - 7:15PM
Crosstalk Among Organs
Room: Chamisa Ballroom 1

Speaker 1 of 5
* Jan Nilsson, Lund University, Sweden

Wednesday, February 07 | 5:00PM - 7:15PM
Crosstalk Among Organs
Room: Chamisa Ballroom 1

Speaker 2 of 5
Viktoria Gusarova, Regeneron Pharmaceuticals, USA
ANGPTL3 Blockade as a Therapeutic Approach for Treatment of Dyslipidemia and Atherosclerosis



Wednesday, February 07 | 5:00PM - 7:15PM
Crosstalk Among Organs
Room: Chamisa Ballroom 1

Speaker 3 of 5
Lilach O. Lerman, Mayo Clinic, USA
New Concepts in Atherosclerotic Renovascular Disease: Current Status

Wednesday, February 07 | 5:00PM - 7:15PM
Crosstalk Among Organs
Room: Chamisa Ballroom 1

Speaker 4 of 5
Joachim Herz, University of Texas Southwestern Medical Center, USA
Multitasking Therapeutics: What Brain Development, Alzheimer’s Disease and Atherosclerosis Have in Common

Wednesday, February 07 | 5:00PM - 7:15PM
Crosstalk Among Organs
Room: Chamisa Ballroom 1

Speaker 5 of 5
Johan Lars Markus Björkegren, Icahn School of Medicine at Mount Sinai, USA
Cardiometabolic Risk Loci Share Downstream Cis- and Trans-Gene Regulation Across Tissues and Diseases

Wednesday, February 07 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Wednesday, February 07 | 7:30PM - 10:00PM
Poster Session 3
Room: Chamisa Ballroom 2


Thursday, February 08 | 7:00AM - 8:00AM
Breakfast
Room: Sagebrush Lobby & Cantina


Thursday, February 08 | 8:00AM - 9:00AM
Keynote Address
Room: Chamisa Ballroom 1

Speaker 1 of 2
* Sekar Kathiresan, Verve Therapeutics, USA

Thursday, February 08 | 8:00AM - 9:00AM
Keynote Address
Room: Chamisa Ballroom 1

Speaker 2 of 2
Jesper Gromada, Regeneron Pharmaceuticals, USA
PCSK9 and ANGPTL3 Inhibitors: A New Era of Lipid-Lowering Therapies

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 1 of 6
* Viktoria Gusarova, Regeneron Pharmaceuticals, USA

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 2 of 6
Jacob Fog Bentzon, Centro Nacional de Investigaciones Cardiovasculares, Spain
Gene-Modified Minipigs: Applications in Atherosclerosis Imaging

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1


Coffee Break

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 4 of 6
Lesca Miriam Holdt, University Hospital, LMU Munich, Germany
Circular RNA in Atherosclerosis

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 5 of 6
Katey Rayner, University of Ottawa, Canada
New Inflammatory Drivers and Biomarkers of Atherosclerosis

Thursday, February 08 | 9:00AM - 11:15AM
Models and Biomarkers for Atherosclerotic Disease
Room: Chamisa Ballroom 1

Speaker 6 of 6
Kelsey E. Jarrett, Baylor College of Medicine, USA
Short Talk: Somatic Genome Editing of Ldlr with AAV-CRISPR Is a Rapid Method for Atherosclerosis Investigation

Thursday, February 08 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 1 of 8
* Thomas Beyer, Eli Lilly and Company, USA

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 2 of 8
Maria Ines Azambuja, Universidade Federal do Rio Grande do Sul, Brazil
The Information that We Need to Advance Knowledge on Atherogenesis Exists and It Is Stored as Levels and Trends of Mortality over the Last Century: Influenza is the Key to Retrieve It

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 3 of 8
Dominique P.V. de Kleijn, University Medical Center Utrecht, Netherlands
Diagnosis of Atherosclerotic Coronary Heart Disease using Plasma Extracellular Vesicle Proteins

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 4 of 8
Trine Pagh Ludvigsen, Novo Nordisk A/S, Denmark
Effect of Statin Treatment Compared to Dietary Cessation on Aortic Plaque Size and Inflammation in a Diet-Induced Atherosclerotic Göttingen Minipig Model

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 5 of 8
Ananthi Rajamoorthi, St. Louis University School of Medicine, USA
Therapeutic Silencing of CIDEC/Fsp27 Is Atheroprotective in Ldlr-/- Mice

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 6 of 8
Divya Sagar, MedImmune, USA
Soluble LOX-1: A Potential Biomarker for SLE and Cardiovascular Comorbidity

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 7 of 8
James Wingrove, CardioDx, USA
The Added Value of a Multi-Omics Approach for the Evaluation of Patients with Suspected Obstructive Coronary Artery Disease

Thursday, February 08 | 2:30PM - 4:30PM
Workshop 3
Room: Chamisa Ballroom 1

Speaker 8 of 8
Jifeng Zhang, University of Michigan, USA
Attenuated Atherosclerosis in Human Apolipoprotein A-II knockin Rabbits

Thursday, February 08 | 4:30PM - 5:00PM
Coffee Available
Room: Chamisa Lobby


Thursday, February 08 | 5:00PM - 6:45PM
Emerging Fields of Research
Room: Chamisa Ballroom 1

Speaker 1 of 4
* Sekar Kathiresan, Verve Therapeutics, USA

Thursday, February 08 | 5:00PM - 6:45PM
Emerging Fields of Research
Room: Chamisa Ballroom 1

Speaker 4 of 4
Siddhartha Jaiswal, Stanford University, USA
Clonal Hematopoiesis in Aging and Atherosclerotic Cardiovascular Disease

Thursday, February 08 | 5:00PM - 6:45PM
Emerging Fields of Research
Room: Chamisa Ballroom 1

Speaker 3 of 4
Hester den Ruijter, University Medical Center, Utrecht, Netherlands
Sex Differences in Cardiovascular Disease

Thursday, February 08 | 5:00PM - 6:45PM
Emerging Fields of Research
Room: Chamisa Ballroom 1

Speaker 2 of 4
Marlys L. Koschinsky, Western University, Canada
Lipoprotein(a): Ready for Prime Time?

Thursday, February 08 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Chamisa Ballroom 1


Thursday, February 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Chamisa Ballroom 2
No registration fees are used to fund alcohol served at this function.

Thursday, February 08 | 7:30PM - 11:00PM
Cash Bar
Room: Chamisa Ballroom 2


Thursday, February 08 | 7:30PM - 11:00PM
Entertainment
Room: Chamisa Ballroom 2
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Friday, February 09 | 10:24AM - 10:24AM
Departure


*Session Chair.